PROM1 and osteosarcoma: Strikingly, the expression of stemness biomarkers was downregulated in osteosarcoma cells after lncRNA SOX2-OT knockdown, including ALDH1, Nanog, Oct4, CD44 and CD133 (Wang Z. et al., 2017).